NFGH
Nan Fung Group Holdings Portfolio holdings
AUM
$63.4M
This Quarter Return
+3.58%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(-7.4%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
82.11%
Holding
47
New
8
Increased
4
Reduced
4
Closed
5
Top Buys
| 1 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$1.48M |
| 2 |
Merus
MRUS
|
$1.45M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$947K |
| 4 |
Replimune Group
REPL
|
$929K |
| 5 |
Travere Therapeutics
TVTX
|
$538K |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$7.84M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$3.13M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$1.85M |
| 4 |
Entrada Therapeutics
TRDA
|
$920K |
| 5 |
TSVT
2seventy bio
TSVT
|
$586K |
Sector Composition
| 1 | Healthcare | 99.77% |
| 2 | Technology | 0.22% |
